The IASLC "Best Of" Series

The Latin America Conference on Lung Cancer (LALCA) is dedicated to addressing the unique challenges and advancements in thoracic oncology within Latin America. This biennial conference brings together healthcare professionals, researchers, and advocates to discuss a wide array of topics, including tumor biology, early detection, surgical and radiotherapy innovations, targeted therapies, immunotherapy, tobacco control, and patient advocacy. Through multidisciplinary collaboration and knowledge exchange, LALCA aims to improve lung cancer outcomes and foster advancements in care across the region.

The Pan-Africa Conference on Lung Cancer (PACLC) is the first multidisciplinary lung cancer conference in Sub-Saharan Africa. This conference is an exclusive gathering for healthcare providers dedicated to improving lung cancer care in the region. Delegates will gain comprehensive knowledge on lung cancer prevention and screening, the latest updates in pathology, genomics, targeted therapy, and immunotherapy, and diagnostic excellence with a focus on differentiating lung cancer from tuberculosis. The event will also address the unique challenges of managing lung cancer in resource-constrained settings and foster future collaborations to enhance care.

The Small Cell Lung Cancer (SCLC) Hot Topic Conference is a leading international forum dedicated to advancing the understanding and treatment of SCLC. Held biennially, this specialized conference brings together researchers, clinicians, and industry experts to share the latest developments in SCLC research. The program encompasses a wide range of topics, including tumor biology, pathology, early detection, therapeutic strategies, and emerging clinical trials. By fostering collaboration and innovation, the meeting aims to accelerate progress in combating this aggressive form of lung cancer.​

The Asia Conference on Lung Cancer (ACLC) addresses key regional challenges, including the high prevalence of genetic mutations, environmental risk factors, and disparities in healthcare access. The conference will focus on expanding early detection through low-dose CT and AI, advancing biomarker testing, and fostering multidisciplinary collaboration among medical oncologists, surgeons, radiologists, pulmonologists, radiation oncologists, pathologists, and all healthcare providers involved in the care of patients with thoracic malignancies. Sessions will explore strategies to improve access to targeted therapies, immunotherapy, and innovative surgical and radiotherapy techniques. Additionally, discussions will highlight public health initiatives, tobacco control, and approaches to reduce healthcare disparities. Education, training, and patient advocacy will remain central themes, ensuring a sustainable and patient-centered approach to lung cancer care across Asia.

This conference aims to advance the understanding of early lung carcinogenesis biology by exploring the molecular, genomic, epigenetic, and immune mechanisms that drive the earliest stages of lung tumor development. The agenda is designed to bridge the gap between basic science, translational, and clinical application, making it valuable for those at the forefront of research, clinical practice, and drug development in the field of early-stage lung cancer.     

The North America Conference on Lung Cancer (NACLC) is a premier event featuring dynamic education sessions, illuminating oral abstracts, and engaging poster presentations. Attendees will explore diverse topics like screening and prevention strategies, disparities, screening methodologies, and disparities influencing screening. Additionally, the conference delves into intricate aspects of surgical management, advanced radiation therapy techniques, breakthroughs in novel therapeutics, and recent advancements in diagnostics and thoracic cancer pathology. NACLC fosters robust networking opportunities, offers insightful case studies, and facilitates direct interaction with leading experts, pushing the boundaries of knowledge and collaboration.